Importantly, intrarenal complement gene expression (C1R, C1QB, C6, C9, C5, MASP2) predicts nonresponse to induction therapy (40), alluding to the potential pathogenic role of intrarenal complement gene expression in chronic kidney disease. This evidence concerns the gene C9 and chronic kidney disease.